Publication Date

2014

Journal Title

J Clin Microbiol

Abstract

The incidence of aztreonam and cephalosporin susceptibility, determined using the revised CLSI breakpoints, for extendedspectrum-beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated. Our analysis showed that results for aztreonam and/or> 1 cephalosporin were reported as susceptible or intermediate for 89.2% of ESBLproducing E coli isolates (569/638 isolates) and 67.7% of ESBL-producing K. pneumoniae isolates (155/229 isolates).

Volume Number

52

Issue Number

7

Pages

2653-2655

Document Type

Article

EPub Date

2014/05/03

Status

Faculty; Northwell Researcher

Facility

School of Medicine; Northwell Health

Primary Department

Occupational Medicine, Epidemiology and Prevention

Additional Departments

Pathology and Laboratory Medicine; Molecular Medicine

PMID

24789185

DOI

10.1128/jcm.03613-13


Share

COinS